HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Convergent evolution and multi-wave clonal invasion in H3 K27-altered diffuse midline gliomas treated with a PDGFR inhibitor.

Abstract
The majority of diffuse midline gliomas, H3 K27-altered (DMG-H3 K27-a), are infiltrating pediatric brain tumors that arise in the pons with no effective treatment. To understand how clonal evolution contributes to the tumor's invasive spread, we performed exome sequencing and SNP array profiling on 49 multi-region autopsy samples from 11 patients with pontine DMG-H3 K27-a enrolled in a phase I clinical trial of PDGFR inhibitor crenolanib. For each patient, a phylogenetic tree was constructed by testing multiple possible clonal evolution models to select the one consistent with somatic mutations and copy number variations across all tumor regions. The tree was then used to deconvolute subclonal composition and prevalence at each tumor region to study convergent evolution and invasion patterns. Somatic variants in the PI3K pathway, a late event, are enriched in our cohort, affecting 70% of patients. Convergent evolution of PI3K at distinct phylogenetic branches was detected in 40% of the patients. 24 (~ 50%) of tumor regions were occupied by subclones of mixed lineages with varying molecular ages, indicating multiple waves of invasion across the pons and extrapontine. Subclones harboring a PDGFRA amplicon, including one that amplified a PDGRFAY849C mutant allele, were detected in four patients; their presence in extrapontine tumor and normal brain samples imply their involvement in extrapontine invasion. Our study expands the current knowledge on tumor invasion patterns in DMG-H3 K27-a, which may inform the design of future clinical trials.
AuthorsSasi Arunachalam, Karol Szlachta, Samuel W Brady, Xiaotu Ma, Bensheng Ju, Bridget Shaner, Heather L Mulder, John Easton, Benjamin J Raphael, Matthew Myers, Christopher Tinkle, Sariah J Allen, Brent A Orr, Cynthia J Wetmore, Suzanne J Baker, Jinghui Zhang
JournalActa neuropathologica communications (Acta Neuropathol Commun) Vol. 10 Issue 1 Pg. 80 (05 31 2022) ISSN: 2051-5960 [Electronic] England
PMID35642016 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2022. The Author(s).
Chemical References
  • Histones
  • Protein Kinase Inhibitors
Topics
  • Child
  • DNA Copy Number Variations
  • Glioma (drug therapy, genetics, pathology)
  • Histones (genetics)
  • Humans
  • Mutation (genetics)
  • Phosphatidylinositol 3-Kinases (genetics)
  • Phylogeny
  • Protein Kinase Inhibitors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: